VARICELLA: OPPORTUNITIES OF FIGHTING WITH «OLD ENEMY» IN PEDIATRIC PRACTICE
Abstract
Key words: children, varicella, vaccination.
(Voprosy sovremennoi pediatrii — Current Pediatrics. 2010;9(5):99-102)
About the Author
M.G. GalitskayaRussian Federation
References
1. Working against Varicella in Europe. 2009.
2. Gershon A.A., Takahashi M., White C.J. Varicella vaccine. In: Plotkin S.A., Orenstein W.A., editors. Vaccines. 3rd ed. Philadelphia (PA): WB Saunders. 1999; 475–507.
3. Centers for Disease Control and Prevention. Prevention of varicella: updated recommendations of the Advisory Committee on Immunization (ACIP). MMWR Morb. Mortal. Wkly Rep. 1999; 48 (RR-06): 1–5.
4. Takahashi M., Gershon A.A. Varicella vaccine. In: Plotkin SA, Mortimer EA, editors. Vaccines. 2nd ed. Philadelphia (PA): WB Saunders.1994: 387–417.
5. Krugman S., Katz S., Gershon A. et al. Infectious diseases of children. St Louis (MO): Mosby. 1992.
6. Takahashi M., Baba K. A live varicella vaccine: its protective effect and immunological aspects of varicella-zoster virus infection. Ed. de la Maza L.M., Peterson E.M. In: Medical virology. New York: Elsevier. 1984: 255–278.
7. ACIP. Centers for Disease Control and Prevention. MMWR. 1996; 45: 1–25.
8. Инфекционная заболеваемость в РФ в 2006-2007 гг. (информационный сборник). ФЦГСЭН МЗ РФ. М. 2007. С. 4.
9. Баранов А.А., Балашов Д.Н., Горелов А.В. и др. Предотвращение ветряной оспы средствами специфической профилактики в Беларуси, Казахстане, России и Украине. Педиатрическая фармакология. 2008; 5 (3): 6–14.
10. Takahashi M., Otsuka T., Okuno Y. et al. Live vaccine used to prevent spread of varicella in children in hospital. Lancet. 1974; 2: 1288–1290.
11. Takahashi M., Yamanishi K. Transformation of hamster and human embryo cells by temperature sensitive mutants of herpes simplex virus type 2. Virology. 1974; 61: 306–311.
12. Takahashi M., Otsuka T., Okuno Y. et al. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet. 1974; 2: 1288–1290.
13. World Health Organization. Varicella vaccine weekly epidemiological report. WHO. Geneva. 1998; 32: 241–248.
14. Ohkusa Y., Sugawara T., Mino M. et al. Varricela vaccination policy subsidy evaluation. Kansenshogaku Zasshi. 2010; 84(2): 159–164.
15. Ozaki T., Matsui Y., Ichikawa T. Clinical trial of the Oka strain of live attenuatedvaricella vaccine on healthy children. Biken J. 984; 7: 39–42.
16. Salzman M.B., Garcia C. Post-exposure varicella vaccination in siblings of children with active varicella. Pediatr. Infect. Dis. J. 1998; 17 (3): 256–257.
17. Asano Y., Nakayama H., Yazaki T. et al. Protection against varicella in family contacts by immediate inoculation with live varicella vaccine. Pediatrics. 1977; 59: 3–7.
18. Asano Y., Nakayama H., Yazaki T. et al. Protective efficacy of vaccination in children in four episodes of natural varicella and zoster in the ward. Pediatrics. 1977; 59: 8–12.
19. Asano Y. Varicella Vaccine: the Japanese Experience. J. Infec. Dis. 1996; 174 (Suppl 3): 310–333.
20. Asano Y., Takahashi M. Clinical and serologic testing of a live varicella vaccine and two-year follow-up for immunity of the vaccinated children. Pediatrics. 1977; 60: 810–814.
21. Asano Y., Nagai T., Miyata T. et al. Long-term protective immunity of recipients of the Oka strain of live varicella vaccine. Pediatrics. 1985; 75 (4): 667–671.
Review
For citations:
Galitskaya M. VARICELLA: OPPORTUNITIES OF FIGHTING WITH «OLD ENEMY» IN PEDIATRIC PRACTICE. Current Pediatrics. 2010;9(5):99-102.
Email this article 
